Hindustan Syringes & Medical Devices Ltd (HMD) has received another Govt order of 265 million AD syringes to supply till September this year (against their original bid for 220 million pcs) against the 350 million pcs tender taken out by the Govt, for which they were L1. HMD is also on track to finish the three orders received from GoI on 0.5 ml AD syringes of 177.5 million pcs by March this year.

HMD initiated investment of over $15 million (approx Rs 100 crore) in May 2020 to mass produce specialty syringes even before purchase orders were even in sight,” said Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd.

From 500 million pcs per annum capacity of 0.5 ml AD Syringes in June 2020, HMD is currently producing at 800 million per annum & hope to achieve capacity of one billion by June & 1.2 billion per annum by September this year for this one size alone. This is the size sought by public healthcare in India and most countries for COVID. For private healthcare the Dispovan disposable syringes are still popular but there is a shift by progressive hospitals who wish to assure their patients of higher injection safety. One injection one syringe.

Over 440 million KOJAK syringes will be supplied to GoI for India’s massive vaccination drive by September including 177 million by April this year alongside supplies of Dispovan to the private hospitals and vaccination clinics.